Telomerase-mediated immortalization preserves the anti-inflammatory activity of dental pulp stem cell extracellular vesicles
-
By
-
Sadiq Umar
-
Yu Lu
-
Sherly Makar
-
Koushik Debnath
-
Wang Li
-
Sreeparna Chakraborty
-
Jalees Rehman
-
Sriram Ravindran
-
June 10, 2026
-
Clinical Scorecard: Immortalization through Telomerase Enhances the Anti-Inflammatory Properties of Extracellular Vesicles from Dental Pulp Stem Cells
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients with inflammatory conditions requiring immunomodulation and tissue repair, as demonstrated in the study. |
| Care Setting | |
Key Highlights
- In vivo studies show comparable reduction in pulmonary edema and inflammatory responses using EVs from both sources.
Guideline-Based Recommendations
Diagnosis
Management
- Consider monitoring inflammatory markers in patients receiving EV therapy.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Individuals with inflammatory conditions and potential for tissue regeneration
Immortalized DPSCs provide a reproducible source of EVs with consistent anti-inflammatory properties.
Clinical Best Practices
- Evaluate patient-specific factors to optimize the use of DPSC-derived EVs in therapy.
Related Resources & Content
